R. Maynard

Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies.

R. Hruban, S. Kern, M. Schutte, 2000, Applied immunohistochemistry & molecular morphology : AIMM.

Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.

J. Minna, P. Zimmerman, J. Geradts, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

C. Moskaluk, J. Herman, S. Baylin, 1997, Cancer research.

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

J. Biegel, B. Weissman, C. Eberhart, 2014, Oncotarget.

TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.

J. Mesirov, P. Tamayo, S. Pomeroy, 2021, Cancer letters.

Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.

J. Barrett, M. Birrer, J. Geradts, 1999, The American journal of pathology.

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

R. Hruban, M. Goggins, S. Kern, 1998, Cancer research.

1012 Fibroblast activation protein regulates human natural killer cell migration

Apsra Nasir, G. Pearson, R. Maynard, 2022, Regular and Young Investigator Award Abstracts.

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

J. Biegel, B. Weissman, C. Eberhart, 2014, Oncotarget.